Publikationen von U. Reichl

Sidorenko, Y.; Reichl, U.: A Model for the Influenza Virus Live-Cycle in a Single Cell. In ICSB: 5th International Congress on Systems Biology: Book of abstracts, S. 382. ICSB : 5th International Congress on Systems Biology, Heidelberg, Germany, 09. Oktober 2004 - 13. Oktober 2004. (2004)

Möhler, L.; Flockerzi, D.; Reichl, U.: Mathematical Model of Virus Replication in Animal Cells. In Chemie Ingenieur Technik, 74 (5), S. 661 - 662. GVC DECHEMA Jahrestagung, Wiesbaden, Germany, 11. Juni 2002 - 13. Juni 2002. (2002)

Trotha, R.; Reichl, U.; Koenig, W.; Koenig, B.: Validation of a T-RFLP Technique for the Precise Qualitative and Quantitative Characterization of Microbioal Communities by Using an Automated High Throughput Multi-Capillary Electrophoresis Device. In Abstracts of the General Meeting of the American Society for Microbiology, N-102, S. 323. 102nd General Meeting of the American Society for Microbiology, Salt Lake City, USA, 19. Mai 2002 - 23. Mai 2002. (2002)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. 6^th MECP (Multistep Enzyme Catalyzed Processes) Congress, Vienna (Austria) (2024)

Genzel, Y.; Göbel, S.; Reichl, U.: Shaking to very high cell densities - perfusion for virus production. Kuhner Large Scale Meeting, Girona (Spain) (2024)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yield. 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI), Rio de Janeiro (Brazil) (2024)

Pelz, L.; Rüdiger, D.; Hein, M.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Engineered defective interfering particles of influenza A virus for antiviral treatment. 33^rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)

Pelz, L.; Rüdiger, D.; Hein, M. D.; Böhme, J.; Bälkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A.; Genzel, Y.; Bruder, D. et al.; Kupke, S. Y.; Reichl, U.: Genetic engineering of Influenza A virus defective interfering particles towards improved antiviral efficacy and potential use as a live vaccine. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Rüdiger, D.; Opitz, P.; Kupke, S. Y.; Reichl, U.: A two-dimensional model to predict influenza virus and defective interfering particle coinfection in tissue-like systems. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Rüdiger, D.; Opitz, P.; Kupke, S. Y.; Reichl, U.: Predicting the antiviral efficacy of defective interfering particles against influenza virus infection in tissues. KSMB-SMB 2024, Seoul (South Korea) (2024)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Discovering Rare Sialylated N glycans Holding O Acetylation or Sulfation within the Site-Specific N glycosylation of Human Serum IgA. SialoGlyco 2024 (International Conference in SialoGlycobiology 2024), Lille (France) (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Including N glycopeptides Bearing Glucuronidated, O Acetylated or Sulfated N glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. 33rd Joint Glycobiology Meeting (JGM) , Hannover (Germany) (2024)

Zuniga-Banuelos, F. J.; Lemke, G.; Hoffmann, M.; Reichl, U.; Rapp, E.: Expanding Glycoproteomics: Including N‑glycopeptides Bearing Glucuronidated, O‑Acetylated or Sulfated N‑glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. EGC 2024 webinar (European Glycoscience Community Webinar Series), online (2024)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. GlycoBioTec 2023, Berlin, Germany (2023)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: Development of a cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. GlycoBioTec 2023, Berlin, Germany (2023)

Alcalá Orozco, E. A.; Huber, N.; Klamt, S.; Rexer, T.; Reichl, U.: A cell-free enzymatic cascade for the synthesis of GDP-fucose - modeling and optimization. 3^rd Japan-Switzerland-Germany Workshop on Biocatalysis and Bioprocess Development , Aichi (Japan) (2023)

Dogra, T.; Pelz, L.; Boehme, J. D.; Baelkner, M.; Kershaw, O.; Marichal-Gallardo, P.; Gruber, A. D.; Genzel, Y.; Bruder, D.; Kupke, S. Y. et al.; Reichl, U.: Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 17^th Vaccine Congress, Glasgow (Scotland) (2023)

Dogra, T.; Pelz, L.; Rüdiger, D.; Kupke, S. Y.; Reichl, U.: Reverse genetics for Influenza a virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. Vir-AI-DIP Workshop , Hamburg (Germany) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16^th PEACe Conference, Sitges (Spain) (2023)